Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

LESSONS LEARNED. This pharmacokinetic study of nivolumab showed that there is little ethnic difference in the handling of nivolumab. Nivolumab was well tolerated in Korean patients. BACKGROUND. This phase I study of nivolumab, an anti‐programmed cell death‐1 (anti‐PD‐1) monoclonal antibody, investig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Lee, Keun‐Wook, Lee, Dae Ho, Kang, Jin Hyoung, Park, Joon Oh, Kim, Se Hyun, Hong, Yong Sang, Kim, Seung Tae, Oh, Do‐Youn, Bang, Yung‐Jue
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813749/
https://ncbi.nlm.nih.gov/pubmed/29158363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0528
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados